©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 108854
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.108854
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.108854
Table 2 Improvement of stool frequency and stool consistency
| Variables | PEG-Chula group | Commercial group | Between group | |||
| mean ± SD | Mean change from baseline (95%CI) | mean ± SD | Mean change from baseline (95%CI) | Mean difference (95%CI) | P value | |
| Stool frequency (time/week) | ||||||
| Baseline (n = 52) | 1.96 ± 0.58 | - | 2.21 ± 0.74 | - | - | 0.181 |
| Week 1 (n = 51) | 6.27 ± 2.97 | 4.31 (3.39-5.23) | 6.16 ± 4.35 | 3.94 (2.95-4.94) | 0.36 (-0.99 to 1.72) | 0.597 |
| Week 2 (n = 50) | 6.20 ± 2.24 | 4.22 (3.29-5.15) | 6.44 ± 3.98 | 4.22 (3.23-5.22) | -0.01 (-1.36 to 1.35) | 0.993 |
| Week 3 (n = 50) | 5.92 ± 2.33 | 3.94 (3.01-4.87) | 6.68 ± 3.8 | 4.46 (3.47-5.46) | -0.53 (-1.88 to 0.83) | 0.448 |
| Week 4 (n = 51) | 6.08 ± 2.42 | 4.12 (3.20-5.03) | 6.04 ± 3.88 | 3.82 (2.83-4.82) | 0.29 (-1.06 to 1.64) | 0.671 |
| Week 5 (n = 51) | 6.50 ± 2.67 | 4.54 (3.62-5.46) | 6.20 ± 3.58 | 3.98 (2.99-4.98) | 0.56 (-0.8 to 1.91) | 0.420 |
| Week 6 (n = 51) | 6.35 ± 2.81 | 4.38 (3.47-5.3) | 7.08 ± 3.5 | 4.86 (3.87-5.86) | -0.48 (-1.83 to 0.87) | 0.488 |
| Week 7 (n = 51) | 6.35 ± 2.42 | 4.38 (3.47-5.3) | 6.04 ± 2.91 | 3.82 (2.83-4.82) | 0.56 (-0.79 to 1.91) | 0.415 |
| Week 8 (n = 50) | 6.00 ± 2.14 | 4.02 (3.09-4.95) | 6.00 ± 3.07 | 3.78 (2.79-4.78) | 0.23 (-1.12 to 1.59) | 0.736 |
| Stool consistency | ||||||
| Baseline (n = 52) | 2.31 ± 0.78 | - | 2.08 ± 0.82 | - | - | 0.30 |
| Week 1 (n = 51) | 4.17 ± 1.02 | 1.87 (1.55-2.18) | 3.53 ± 1.15 | 1.45 (1.12-1.78) | 0.41 (-0.04 to 0.87) | 0.075 |
| Week 2 (n = 50) | 4.70 ± 0.74 | 2.40 (2.08-2.72) | 4.01 ± 0.96 | 1.93 (1.61-2.26) | 0.47 (0.01 to 0.93) | 0.045 |
| Week 3 (n = 50) | 4.55 ± 0.92 | 2.24 (1.92-2.57) | 3.96 ± 0.87 | 1.88 (1.56-2.21) | 0.36 (-0.10 to 0.82) | 0.123 |
| Week 4 (n = 51) | 4.65 ± 0.83 | 2.34 (2.02-2.66) | 4.08 ± 0.78 | 2.00 (1.67-2.32) | 0.34 (-0.11 to 0.80) | 0.142 |
| Week 5 (n = 51) | 4.48 ± 0.54 | 2.17 (1.85-2.49) | 4.15 ± 0.88 | 2.07 (1.74-2.40) | 0.10 (-0.36 to 0.55) | 0.675 |
| Week 6 (n = 51) | 4.36 ± 0.57 | 2.05 (1.73-2.37) | 4.23 ± 0.79 | 2.16 (1.83-2.48) | -0.11 (-0.56 to 0.35) | 0.650 |
| Week 7 (n = 51) | 4.30 ± 0.49 | 2.00 (1.68-2.31) | 4.00 ± 0.88 | 1.92 (1.59-2.25) | 0.08 (-0.38 to 0.53) | 0.740 |
| Week 8 (n = 50) | 4.18 ± 0.38 | 1.87 (1.55-2.2) | 4.10 ± 0.73 | 2.02 (1.69-2.34) | -0.14 (-0.60 to 0.32) | 0.546 |
- Citation: Tran DL, Sintusek P. Efficacy and palatability of the developed polyethylene glycol-based formula for the treatment of children with functional constipation. World J Clin Pediatr 2025; 14(4): 108854
- URL: https://www.wjgnet.com/2219-2808/full/v14/i4/108854.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.108854